用于预测克洛沙剂量的人口药理动力学模型的验证
Massimo Berneri1, Uma Jha1, Seán O'Halloran2
1Schools of Medicine & Biomedical Sciences, University of Western Australia, Crawley, Western Australia, Australia.
克洛扎的血度因个人因素而有显著差异,目前的模型无法预测这些随时间变化的变化. 需要新的模型来准确指导克洛扎的剂量,并改善患者的治疗结果.
科学领域:
- 药理动力学和药理动力学
- 精神病学药物治疗 精神病学药物治疗
- 药物新陈代谢 药物新陈代谢
背景情况:
- 克洛扎对于严重的精神分裂症至关重要,但具有毒性风险.
- 治疗药物监测是通过度-反应关系来证明的.
- 克洛扎血度的变化受细胞染色体P450 1A2 (CYP1A2) 相互作用的影响.
研究的目的:
- 开发和验证克洛札的种群药动力学模型.
- 评估现有的克洛扎模型的预测性能.
- 为了确定影响克洛沙药理动学的关键共变量.
主要方法:
- 收集了127名克洛扎治疗患者的数据,其血度为1048.
- 使用早期阶段数据 (前6周) 构建了一个人群药理动力学模型.
- 测试了该模型随时间推移的预测性能,并将其与6个已发表的模型进行了比较.
主要成果:
- 性,吸烟和弗洛沃胺显著影响了克洛扎的清除.
- 开发的模型显示了可接受的短期 (26周) 预测性能.
- 现有的已发表的模型未能通过外部验证,预测准确性不佳.
- 用患者数据进行贝叶斯更新改善了预测,但长期没有达到可接受的性能.
结论:
- 克洛扎宾的协变剂度关系在人群之间和随着时间的推移而有所不同.
- 目前克洛扎的种群药动力学模型是不充分的.
- 准确的克洛扎剂量要求采用能够捕捉动态共变量影响的模型.
更多相关视频
07:31Implementation of a Real-Time Psychosis Risk Detection and Alerting System Based on Electronic Health Records using CogStack
Published on: May 15, 2020
00:05A Semi-Quantitative Drug Affinity Responsive Target Stability DARTS assay for studying Rapamycin/mTOR interaction
Published on: August 27, 2019
相关概念视频
Analysis of Population Pharmacokinetic Data
Pharmacokinetic Models: Comparison and Selection Criterion
Physiological models take a detailed approach by considering specific molecular processes. They can predict drug distribution, metabolism, and elimination changes, providing a comprehensive understanding of how drugs interact with the body.
Physiological Pharmacokinetic Models: Assumption with Protein Binding
Physiological Pharmacokinetic Models: Incorporating Hepatic Transporter-Mediated Clearance
A recent model describes pravastatin's hepatobiliary excretion,...
Nonlinear Pharmacokinetics: Dependence of Elimination Half-Life and Dose Clearance
A study on guinea pigs examined the...
Pharmacokinetic Models: Overview
There are three primary types of models: empirical, compartment, and physiological. Empirical models, with minimal...
